Tower Research Capital LLC (Trc) Axsome Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 642 shares of AXSM stock, worth $70,299. This represents 0.0% of its overall portfolio holdings.
Number of Shares
642
Previous 4,583
85.99%
Holding current value
$70,299
Previous $368,000
84.51%
% of portfolio
0.0%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding AXSM
# of Institutions
332Shares Held
38.3MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$459 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$437 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$361 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$258 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$115 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.7B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...